Back

Lipid nanoparticle delivery of siRNA to dorsal root ganglion neurons to treat pain

Han, X.; Petrova, V.; Song, Y.; Cheng, Y.-T.; Jiang, X.; Zhou, H.; Hu, C.; Chen, D. S.; Yong, H. J.; Kim, H. W.; Zhang, B.; Barkai, O.; Jain, A.; Renthal, W.; Lirk, P.; Woolf, C. J.; Shi, J.

2025-01-24 neuroscience
10.1101/2025.01.23.633455 bioRxiv
Show abstract

Sensory neurons within the dorsal root ganglion (DRG) are the primary trigger of pain, relaying activity about noxious stimuli from the periphery to the central nervous system; however, targeting DRG neurons for pain management has remained a clinical challenge. Here, we demonstrate the use of lipid nanoparticles (LNPs) for effective intrathecal delivery of small interfering RNA (siRNA) to DRG neurons, achieving potent silencing of the transient receptor potential vanilloid 1 (TRPV1) ion channel that is predominantly expressed in nociceptor sensory neurons. This leads to a reversible interruption of heat-, capsaicin-, and inflammation-induced nociceptive conduction, as observed by behavioral outputs. Our work provides a proof-of-concept for intrathecal siRNA therapy as a novel and selective analgesic modality.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.